Chemoinformaics analysis of 6BETA-HYDROXY-CARNOSOL
| Molecular Weight | 346.423 | nRot | 1 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 20 |
| Exact Molecular Weight | 346.178 | nRing | 5 |
| Solubility: LogS | -3.893 | nHRing | 2 |
| Solubility: LogP | 3.495 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 54.7466 |
| nHD | 3 | BPOL | 28.6874 |
| QED | 0.537 |
| Synth | 5.539 |
| Natural Product Likeliness | 2.714 |
| NR-PPAR-gamma | 0.962 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.01 |
| HIA | 0.016 |
| CACO-2 | -4.758 |
| MDCK | 0.0000233 |
| BBB | 0.664 |
| PPB | 0.978015 |
| VDSS | 1.395 |
| FU | 0.0225546 |
| CYP1A2-inh | 0.027 |
| CYP1A2-sub | 0.792 |
| CYP2c19-inh | 0.075 |
| CYP2c19-sub | 0.866 |
| CYP2c9-inh | 0.397 |
| CYP2c9-sub | 0.931 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.255 |
| CYP3a4-inh | 0.256 |
| CYP3a4-sub | 0.538 |
| CL | 5.117 |
| T12 | 0.137 |
| hERG | 0.003 |
| Ames | 0.079 |
| ROA | 0.827 |
| SkinSen | 0.467 |
| Carcinogencity | 0.067 |
| EI | 0.332 |
| Respiratory | 0.427 |
| NR-Aromatase | 0.941 |
| Antiviral | No |
| Prediction | 0.677354 |